400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR1900020656
尚未开始
/
/
/
2019-01-12
/
/
結直腸癌
Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer
Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer
This study aims to develop a tailored risk communication intervention (TRCI) based on results of the systematic review on interventions to promote colonoscopy screening conducted by the principal investigator, and examine its effectiveness in promoting colonoscopy uptake among Chinese first-degree relatives (FDRs).
随机平行对照
卫生服务研究
Each family will be randomly assigned to TRSI group or control group with a 1:1 ratio using a sequence of block randomization number to assign cluster numbers equally to each group. A statistician will generates a random number sequence by computer software, a randomly mixed block size at 4-8 will b
Due to the nature of the intervention, blinding of participants and researchers is impossible. To avoid biased estimated of treatment effect, online survey will be conducted.?Participant will submit the web form back to the web server directly when the finish the assessment and the intervener are not able to influence the assessment.
N/A
/
105
/
2019-03-04
2019-10-31
/
(1) aged 40-75 years or 10 years before the age the relative was diagnosed; (2) individuals with 1 FDR with CRC at <60 years or with 2 or more FDRs with CRC at any age; (3) have not had a colonoscopy before; (4) with access to We-chat themselves or through close family members living in the same household; (5)able to read and speak Chinese. (6) living in Shenzhen;
请登录查看(1) have history of cancer or inflammatory bowel disease; (2) recently participate in another study or previously participated in cancer risk counseling or study; (3) with doctor-diagnosed psychiatric illness.;
请登录查看香港中文大學醫學院那打素護理學院
/
浙江道尔生物科技有限公司2026-04-16
新药创始人2026-04-16
丁香园 Insight 数据库2026-04-16
2021至2023年理赔服务2026-04-16
干细胞与外泌体2026-04-16
细胞与基因治疗领域2026-04-16
北京药研汇2026-04-16
正大天晴药业集团2026-04-16
复融生物2026-04-16
先通医药2026-04-16